In this article, we will take a look at the most promising education stocks according to hedge funds. With positive digital learning dynamics and accelerated enrollment rates, education platforms are scaling globally. The trend first started when COVID-19 hit, prompting institutions to rush to adopt digital platforms. Since then, the global higher education market has [...]
ULTA — 6.4 Hold. The quarter was actually good on the surface: +5.8% comps, $3.90B revenue beating estimates, record 46.7M loyalty members. The market didn't care. SG&A jumped 23% to 25.7% of sales — up 230 bps year over year — and operating income fell 7.9% on 11.8% revenue growth.
Health Catalyst (NASDAQ:HCAT – Get Free Report) released its earnings results on Thursday. The company reported $0.08 earnings per share for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.02), FiscalAI reports. The firm had revenue of $74.68 million for the quarter, compared to the
Allogene Therapeutics (NASDAQ:ALLO – Get Free Report) issued its earnings results on Thursday. The company reported ($0.17) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.25) by $0.08, FiscalAI reports. Allogene Therapeutics Trading Down 6.1% Shares of NASDAQ ALLO traded down $0.
Clearmind Medicine (NASDAQ:CMND – Get Free Report) released its quarterly earnings results on Thursday. The company reported ($3.32) earnings per share (EPS) for the quarter, FiscalAI reports. Clearmind Medicine Stock Down 11.6% Clearmind Medicine stock traded down $0.11 during mid-day trading on Thursday, hitting $0.83. 146,
